// App-Quantinova.ai

103 : Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.

Researchers

Presenter

  • Nicolas Guibert

Principal Investigators

  • Greg Jones

  • John F. Beeler

  • Clive D. Morris

  • Vincent Plagnol

  • Jean Mourlanette

  • Myriam Delaunay

  • Isabelle Rouquette

  • Gilles Favre

  • Anne Pradines

  • Julien Mazieres

Medical Centers

  • Centre de Recherche en Cancerologie de Toulouse, CRCT, Toulouse, France

  • Inivata, Cambridge, United Kingdom

  • Inivata Ltd., Research Triangle Park, NC

  • Inivata, Cheshire, United Kingdom

  • Inivata, Cambridge, United Kingdom

  • Toulouse University Hospital, Toulouse, France

  • Institut Claudius Regaud, IUCT-Oncopole, Laboratoire de Biologie Medicale Oncologique, Toulouse, France

  • Hopital Larrey Centre Hospitalier Universitaire Toulouse, Toulouse, France

Locations

  • France

  • United Kingdom

  • United States

Companies

  • Inivata Ltd

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating DNA

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • NCT02827344

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved